Search Results - "Montalbano, Mauro"
-
1
Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
Published in International journal of molecular sciences (30-06-2023)“…Glypican-3 (GPC-3) is a heparin sulfate proteoglycan located extracellularly and anchored to the cell membrane of transformed hepatocytes. GPC-3 is not…”
Get full text
Journal Article -
2
Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells
Published in Scientific reports (17-01-2018)“…This report identifies mitochondrial DNA (mtDNA) as a target and active mediator that links low-level oxidative stress to inflammatory response in pulmonary…”
Get full text
Journal Article -
3
RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction
Published in Nature communications (27-08-2020)“…Oligomeric assemblies of tau and the RNA-binding proteins (RBPs) Musashi (MSI) are reported in Alzheimer’s disease (AD). However, the role of MSI and tau…”
Get full text
Journal Article -
4
TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
Published in Neurobiology of disease (01-12-2020)“…Proteinaceous aggregates are major hallmarks of several neurodegenerative diseases. Aggregates of post-translationally modified transactive response (TAR)-DNA…”
Get full text
Journal Article -
5
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease
Published in Acta neuropathologica communications (10-08-2020)“…The transcription factor, p53, is critical for many important cellular functions involved in genome integrity, including cell cycle control, DNA damage…”
Get full text
Journal Article -
6
Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
Published in Frontiers in molecular neuroscience (03-12-2021)“…Tau protein is a known contributor in several neurodegenerative diseases, including Alzheimer's disease (AD) and frontotemporal dementia (FTD). It is…”
Get full text
Journal Article -
7
Hazardous air pollutants and primary liver cancer in Texas
Published in PloS one (10-10-2017)“…The incidence of hepatocellular carcinoma (HCC), the most common primary liver cancer, is increasing in the US and tripled during the past two decades. The…”
Get full text
Journal Article -
8
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer's disease
Published in Acta neuropathologica communications (26-10-2018)“…Alzheimer's disease (AD) is the most common neurodegenerative disorder associated with structural and functional alterations of brain cells causing progressive…”
Get full text
Journal Article -
9
Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion
Published in PloS one (13-04-2016)“…Isolation of hepatocytes from cirrhotic human livers and subsequent primary culture are important new tools for laboratory research and cell-based therapeutics…”
Get full text
Journal Article -
10
Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinoma (Review)
Published in Oncology reports (01-03-2017)“…Glypican-3 (GPC-3), a transmembrane heparan sulfate proteoglycan (HSPG), has recently been investigated as a player in tissue-dependent cellular signaling,…”
Get full text
Journal Article -
11
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
Published in Brain pathology (Zurich, Switzerland) (01-01-2023)“…Accumulation of pathological tau aggregates is a prominent feature in tauopathies that leads during the course of the diseases to neuronal dysfunction before…”
Get full text
Journal Article -
12
Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia
Published in Cell reports (Cambridge) (20-07-2021)“…Aging, pathological tau oligomers (TauO), and chronic inflammation in the brain play a central role in tauopathies, including Alzheimer’s disease (AD) and…”
Get full text
Journal Article -
13
RNA‐Binding Proteins Musashi and Tau Aggresome in Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2023)“…Background Tauopathies, such as Alzheimer’s disease (AD), are characterized by the accumulation of toxic tau oligomers in the brain and accumulation of…”
Get full text
Journal Article -
14
Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
Published in The Journal of biological chemistry (01-04-2022)“…Ubiquitin-modified tau aggregates are abundantly found in human brains diagnosed with Alzheimer’s disease (AD) and other tauopathies. Soluble tau oligomers…”
Get full text
Journal Article -
15
Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration
Published in Aging cell (01-12-2019)“…The exact mechanisms leading to neurodegeneration in Alzheimer's disease (AD) and other tauopathies are not yet entirely understood. However, it is known that…”
Get full text
Journal Article -
16
Modulating disease-relevant tau oligomeric strains by small molecules
Published in The Journal of biological chemistry (30-10-2020)“…The pathological aggregation of tau plays an important role in Alzheimer's disease and many other related neurodegenerative diseases, collectively referred to…”
Get full text
Journal Article -
17
Tau modulates mRNA transcription, alternative polyadenylation (APA) profiles of hnRNPs, chromatin remodeling and spliceosome complexes
Published in The FASEB journal (01-05-2022)“…Tau protein is a known contributor in several neurodegenerative diseases, including Alzheimer ’s disease (AD) and frontotemporal dementia (FTD). It is…”
Get full text
Journal Article -
18
Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
Published in Cellular and molecular life sciences : CMLS (01-04-2022)“…Background Alzheimer’s disease (AD) is characterized by progressive cognitive decline due to accumulating synaptic insults by toxic oligomers of amyloid beta…”
Get full text
Journal Article -
19
Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice
Published in Science translational medicine (03-07-2024)“…Pathological tau aggregates cause cognitive decline in neurodegenerative tauopathies, including Alzheimer's disease (AD). These aggregates are prevalent within…”
Get more information
Journal Article -
20
Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies
Published in Cell death & disease (04-05-2020)“…Tau aggregates propagate in brain cells and transmit to neighboring cells as well as anatomically connected brain regions by prion-like mechanisms. Soluble tau…”
Get full text
Journal Article